Pharma Markets

US Psoriasis Market Analysis and Competitive Landscape Highlights

By Fore Pharma | Published Date: May 24, 2020 | On-Demand Data

US Psoriasis Market Analysis and Competitive Landscape Highlights – 2020, provides comprehensive insights into Psoriasis pipeline products, Psoriasis epidemiology, Psoriasis market valuations and forecast, Psoriasis drugs sales and competitive landscape in the US.

Research Scope:

– Psoriasis Pipeline: Drugs in clinical trials for the treatment of Psoriasis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
– Psoriasis Epidemiology: Number of patients diagnosed (prevalence) with Psoriasis in the US
– Drugs sales: Sales revenues for Psoriasis drugs in the US
– Market valuations: US Psoriasis market size for in 2019; find out how the market advanced from 2016 and forecast to 2025
– Drugs market share: Market shares for key Psoriasis drugs in the US

This research helps executives to

– Support monitoring and reporting national Psoriasis market analysis and sales trends
– Track competitor drugs sales and market share in the US Psoriasis market
– Track competitive developments in Psoriasis market and present key issues and learnings
– Synthesize insights for Psoriasis market and products to drive business performance
– Answer key business questions about the Psoriasis market
– Evaluate commercial market opportunity assessment, positioning, and segmentation for Psoriasis products
– Supports decision making in R&D to long term marketing strategies

Table of Contents


1) Psoriasis Treatments
2) Psoriasis Drugs Pipeline
3) US Psoriasis Epidemiology
4) Marketed Drugs for Psoriasis in the US
5) Psoriasis Market Size and Forecast
6) Psoriasis Drugs Sales and Forecast
7) Psoriasis Market Competitive Landscape
8) Methodology
9) Contact us

List of Tables


1. Psoriasis Phase 3 Clinical Trials, 2020
2. Psoriasis Phase 2 Clinical Trials, 2020
3. Psoriasis Phase 1 Clinical Trials, 2020
4. Psoriasis Epidemiology, US, 2016 – 2025
5. Marketed Drugs for Psoriasis, US, 2019
6. Psoriasis Market Size and Forecast ($mn), US, 2016 – 2025
7. Psoriasis Drugs Sales ($mn), US, 2016 – 2025

List of Figures


1. Psoriasis Epidemiology, US, 2016 – 2025
2. Psoriasis Market Size and Forecast ($mn), US, 2016 – 2025
3. Psoriasis Drugs Market Share (%), US, 2019

Format


Dispatch format is XLSX.

Purchase Checkout Added to cart
face
  • Contact Nick
  •  Email
  •  Contact
  • I was looking for specific epidemiology and utilization data for our emerging therapy situation analysis. It was time sensitive. Your team helped me with the right data and methodologies. Thank you very much.
    - Director, Big Pharma

    About

    • About us
    • Research Store
    • Research Store
    • News
    • Contact

    Trusted By
    Top Companies